IP Verse

Antibodies With Modified Affinity To Fcrn That Promote Antigen Clearance

EP2552955

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP11714860A
Filing Date
Mar 30, 2011
Status
Revoked
Sep 23, 2022
Grant Date
May 3, 2017
External Links
Slate, Register

Biblio Summary

The patent EP2552955B1 was granted on May 3, 2017 by Chugai Seiyaku Kabushiki Kaisha The patent is currently Revoked.

Oppositions Filed by other Companies on the Patent

The table below shows 6 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SHIRE HUMAN GENETIC THERAPIES, INC.Feb 5, 2018ADMISSIBLE
TILLOTTS PHARMA AGFeb 5, 2018ADMISSIBLE
ABLYNX N.V.Feb 2, 2018ADMISSIBLE
GLAXO GROUP LIMITEDFeb 2, 2018ADMISSIBLE
MURPHY, COLM DAMIENFeb 2, 2018ADMISSIBLE
ALEXION PHARMACEUTICALS, INC.Feb 2, 2018WITHDRAWN

More Opposed Patents of Chugai Seiyaku Kabushiki Kaisha

The table below shows the patents of Chugai Seiyaku Kabushiki Kaisha that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3296395Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular FusionJun 19, 20241
EP3815688Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineDec 6, 20232
EP2679681Fc Riib-Specific Fc AntibodyNov 15, 20231

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents